Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000235181 corresponds to a human pseudogene named AC245036.2, described as “pseudogene similar to part of leukocyte immunoglobulin-like receptor proteins.” This sequence is classified as a pseudogene—meaning it does not encode a functional protein product, but shows sequence similarity to the protein-coding genes of the LILR (leukocyte immunoglobulin-like receptor) family. LILRs are involved in regulating immune responses, but this pseudogene has no known function, does not serve as a drug target, and is not implicated in disease processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of leukocyte immunoglobulin-like receptor proteins (AC245036.2).